Earnings ·
Chemours reports Q3 net income of $196M, or $1.29 per diluted share
CCChemours Co
The Chemours Company reported third-quarter 2026 net sales of $1.54 billion and net income attributable to shareholders of $196 million, or $1.29 per diluted share, compared with $46 million in the prior-year period. Adjusted EBITDA rose 6% year-over-year to $200 million, driven by pricing strength in Titanium Technologies and growth in Advanced Performance Materials. The quarter included a $150 million benefit from PFAS insurance proceeds related to a New Jersey settlement. Additionally, the company completed the sale of its Kuan Yin property for approximately $340 million. Chemours is a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials.